These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: [Treatment of fistulating pouchitis with tumour necrosis factor-alpha-inhibitor (infliximab)].
    Author: Semb S, Nordgaard-Lassen I.
    Journal: Ugeskr Laeger; 2008 Dec 08; 170(50):4134-5. PubMed ID: 19091194.
    Abstract:
    The surgical first choice treatment for patients with ulcerative colitis (UC) involves total proctocolectomy with ileal pouch-anal anastomosis (IPAA). Postoperative development of pouch-related fistula is a rare complication, but it is associated with significant morbidity, a high recurrence rate and is a major cause of pouch failure. We report the use of infliximab, a monoclonal antibody to tumour necrosis factor-alpha, in three patients who developed pouch-related fistula after undergoing IPAA surgery for UC.
    [Abstract] [Full Text] [Related] [New Search]